NCT03069248View on ClinicalTrials.gov

Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 1, 2000

Primary Completion Date

September 17, 2009

Study Completion Date

September 17, 2009

Conditions
Follicular Lymphoma
Interventions
DRUG

Rituximab

DRUG

Alpha Interferon

Trial Locations (1)

M4N 3M5

Sunnybrook Health Sciences Centre, Odette Cancer Centre, Toronto

All Listed Sponsors
lead

Sunnybrook Health Sciences Centre

OTHER

NCT03069248 - Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha Interferon | Biotech Hunter | Biotech Hunter